找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Nuclear Medicine and Immunology; Sara Harsini,Abass Alavi,Nima Rezaei Book 2022 Springer Nature Switzerland AG 2022 Radioimmunotherapy.Mol

[復(fù)制鏈接]
樓主: magnify
11#
發(fā)表于 2025-3-23 11:40:08 | 只看該作者
111Indium-Labeled Leukocyte Imaging of Infection and Inflammation,ey provide high specificity in the detection of infection and inflammation. Despite advances in advanced tomographic imaging such as positron emission tomography (PET)/computed tomography (CT) and magnetic resonance imaging (MRI), or new scintigraphic agents like radiolabeled antibodies, radiolabele
12#
發(fā)表于 2025-3-23 14:53:33 | 只看該作者
2-[18F]FDG PET Imaging of Infection and Inflammation,ill weak for assessing infections, inflammatory, and autoimmune diseases. This chapter introduces the utility and limitations of 2-[.F]FDG PET for the diagnosis and assessment of treatment in infections, inflammatory, and autoimmune diseases.
13#
發(fā)表于 2025-3-23 20:55:05 | 只看該作者
14#
發(fā)表于 2025-3-23 22:41:29 | 只看該作者
Radionuclide Therapy and Immunomodulation,odies, or other ligands enabling specific accumulation within the tumor site following systemic administration. These isotopes then provide protracted, low-dose rate radiation to the tumor as the isotope decays. Given its similarity to EBRT, it is likely that TRT is capable of promoting an antitumor
15#
發(fā)表于 2025-3-24 05:17:13 | 只看該作者
16#
發(fā)表于 2025-3-24 06:51:23 | 只看該作者
17#
發(fā)表于 2025-3-24 13:09:53 | 只看該作者
18#
發(fā)表于 2025-3-24 16:38:15 | 只看該作者
Radioimmunotherapy of Acute Leukemia,IT efforts to improve outcomes of HCT for high-risk leukemias and MDS, the tumor-associated target antigens that have been used to deliver radiation to sites of disease, as well as the relative merits and limitations of individual radionuclides, including alpha- and beta-emitters. We also appraise r
19#
發(fā)表于 2025-3-24 21:48:08 | 只看該作者
20#
發(fā)表于 2025-3-25 01:13:04 | 只看該作者
Book 2022ique will play an increasingly important role in the management of patients with inflammatory conditions in the future...The book also explores the growing role of nuclear medicine and molecular imaging in the diagnosis and treatment of cancer. The rapid pace of change has been fueled by advances in
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 19:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
泽州县| 磐安县| 扬州市| 建湖县| 遂宁市| 福安市| 拉萨市| 新营市| 盖州市| 象山县| 沂水县| 双流县| 平原县| 循化| 巴林左旗| 仙居县| 黄浦区| 阿勒泰市| 通海县| 营口市| 汉寿县| 奈曼旗| 清新县| 望奎县| 临安市| 牟定县| 运城市| 遂平县| 离岛区| 双辽市| 新昌县| 乐平市| 分宜县| 会泽县| 信阳市| 甘孜县| 富源县| 分宜县| 元氏县| 新沂市| 兴城市|